ATF3 and neoplasm: ATF3 (activating transcription factor 3) has conventionally been characterized in oncological research as a stress-inducible transcription factor that typically exerts a negative regulatory influence on the p38 MAPK pathway within cells, potentially suppressing tumor growth and invasion [21].